LONDON--(BUSINESS WIRE)--LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology and innovation company, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance ...
DULUTH — Aspirus St. Luke’s recently launched a fully operational extracorporeal membrane oxygenation program designed to rapidly initiate life-saving heart and lung support for critically ill ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results